|C - Cardiovascular System|
|C10 - Lipid Modifying Agents|
The DDDs are based on the treatment of hypercholesterolemia.
|C10A - Lipid Modifying Agents, plain|
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
|C10AA - Hmg Coa Reductase Inhibitors|
This group comprises agents which act as competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase).
Atorvastatin in combination with amlodipine is classified in C10BX03.
|C10AA04 - Fluvastatin|
|Dose||Route of administration||Note|
|60 mg||O|| |